<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02569749</url>
  </required_header>
  <id_info>
    <org_study_id>SAHS2</org_study_id>
    <nct_id>NCT02569749</nct_id>
  </id_info>
  <brief_title>Sleep Apnea Screening</brief_title>
  <official_title>Sleep Apnea-Hypopnea Syndrome Screening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arrhythmia Network Technology S.L.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arrhythmia Network Technology S.L.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the incidence of Sleep Apnea-Hypopnea Syndrome (SAHS), both obstructive and
      central, in patients with: 1) pacemaker indication; 2) implantable cardioverter defibrillator
      (ICD) or cardiac resynchronization therapy (CRTD), 3) heart failure and preserved left
      ventricular ejection fraction (LVEF) and 4) heart failure and reduced LVEF.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Administrative reasons
  </why_stopped>
  <start_date>June 2015</start_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Percentage of patients with SAHS in patients with pacemaker indication</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients with SAHS in patients with ICD or CRTD therapy</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients with SAHS in patients with heart failure and preserved LVEF</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients with SAHS in patients with reduced LVEF</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with obstructive sleep apnea in all groups</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with central sleep apnea in all groups</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Sleep Apnea/Hypopnea Syndrome</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Patients with pacemaker indication (pacemaker already implanted or to be implanted)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Patients with ICD or CRTD therapy indication (device already implanted or to be implanted)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>Patients with heart failure an preserved LVEF (40-50%)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <description>Patients with heart failure and reduced LVEF (&lt;40%)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Berlin and Epworth questionaries</intervention_name>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sleep apnea monitoring in those patients in whom a pacemaker with monitoring apnea system has been implanted.</intervention_name>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Night polygraph / Polysomnography</intervention_name>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients to be included in the registry:

          -  200 patients with pacemaker indication in whom a pacemaker with sleep apnea monitoring
             system has been implanted.

          -  100 patients with pacemaker indication in whom a pacemaker with no sleep apnea
             monitoring system has been implanted.

          -  100 patients with ICD or CRDT therapy indication.

          -  100 patients with heart failure and preserved LVEF (40-50%).

          -  100 patients with heart failure and reduced LVEF (&lt;40%).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  No previous diagnosis of sleep apnea

          -  Fulfilling at least one of the following:

               1. Pacemaker indication

               2. ICD or CRTD therapy indication

               3. Heart failure and preserved LVEF (40-50%)

               4. Heart failure and reduced LVEF (&lt;40%)

          -  Signed informed consent

        Exclusion Criteria:

          -  Age younger than 18 years

          -  Renal hemodialysis

          -  Cardiac transplant indication

          -  Women who are pregnant

          -  Advanced cancer

          -  Enrollment in another investigational study

          -  Able and willing to comply with all testing and requirements

          -  Patient not suitable for inclusion due to psychiatric conditions or short life
             expectancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Infanta Cristina</name>
      <address>
        <city>Badajoz</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Burgos</name>
      <address>
        <city>Burgos</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Ciudad Real</name>
      <address>
        <city>Ciudad Real</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HM Hospitales</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Fuenlabrada</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Nuestra Señora de Sonsoles</name>
      <address>
        <city>Ávila</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep. 1997 Sep;20(9):705-6.</citation>
    <PMID>9406321</PMID>
  </reference>
  <reference>
    <citation>Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993 Apr 29;328(17):1230-5.</citation>
    <PMID>8464434</PMID>
  </reference>
  <reference>
    <citation>Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008 Aug;31(8):1079-85.</citation>
    <PMID>18714779</PMID>
  </reference>
  <reference>
    <citation>Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, Stubbs R, Hla KM. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008 Aug;31(8):1071-8.</citation>
    <PMID>18714778</PMID>
  </reference>
  <reference>
    <citation>Ronald J, Delaive K, Roos L, Manfreda J, Bahammam A, Kryger MH. Health care utilization in the 10 years prior to diagnosis in obstructive sleep apnea syndrome patients. Sleep. 1999 Mar 15;22(2):225-9.</citation>
    <PMID>10201067</PMID>
  </reference>
  <reference>
    <citation>Fietze I, Röttig J, Quispe-Bravo S, Riedel F, Witte J, Baumann G, Witt C. Sleep apnea syndrome in patients with cardiac pacemaker. Respiration. 2000;67(3):268-71.</citation>
    <PMID>10867594</PMID>
  </reference>
  <reference>
    <citation>Garrigue S, Pépin JL, Defaye P, Murgatroyd F, Poezevara Y, Clémenty J, Lévy P. High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation. 2007 Apr 3;115(13):1703-9. Epub 2007 Mar 12.</citation>
    <PMID>17353437</PMID>
  </reference>
  <reference>
    <citation>Pépin JL, Chouri-Pontarollo N, Tamisier R, Lévy P. Cheyne-Stokes respiration with central sleep apnoea in chronic heart failure: proposals for a diagnostic and therapeutic strategy. Sleep Med Rev. 2006 Feb;10(1):33-47. Epub 2005 Dec 22. Review.</citation>
    <PMID>16376589</PMID>
  </reference>
  <reference>
    <citation>Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol. 2006 Jan 4;106(1):21-8.</citation>
    <PMID>16321661</PMID>
  </reference>
  <reference>
    <citation>Tremel F, Pépin JL, Veale D, Wuyam B, Siché JP, Mallion JM, Lévy P. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J. 1999 Aug;20(16):1201-9.</citation>
    <PMID>10448029</PMID>
  </reference>
  <reference>
    <citation>Defaye P, de la Cruz I, Martí-Almor J, Villuendas R, Bru P, Sénéchal J, Tamisier R, Pépin JL. A pacemaker transthoracic impedance sensor with an advanced algorithm to identify severe sleep apnea: the DREAM European study. Heart Rhythm. 2014 May;11(5):842-8. doi: 10.1016/j.hrthm.2014.02.011. Epub 2014 Feb 19.</citation>
    <PMID>24561163</PMID>
  </reference>
  <reference>
    <citation>Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, Roselle GA. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998 Jun 2;97(21):2154-9.</citation>
    <PMID>9626176</PMID>
  </reference>
  <reference>
    <citation>Arias MA, García-Río F, Alonso-Fernández A, Sánchez AM. [Sleep apnea-hypopnea syndromes and heart failure]. Rev Esp Cardiol. 2007 Apr;60(4):415-27. Review. Spanish.</citation>
    <PMID>17521550</PMID>
  </reference>
  <reference>
    <citation>Kasai T, Bradley TD. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardiol. 2011 Jan 11;57(2):119-27. doi: 10.1016/j.jacc.2010.08.627. Review.</citation>
    <PMID>21211682</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2015</study_first_submitted>
  <study_first_submitted_qc>October 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2015</study_first_posted>
  <last_update_submitted>November 2, 2015</last_update_submitted>
  <last_update_submitted_qc>November 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

